State Legislatures Take Action: Advancing Alzheimer’s Training for First Responders

Alzheimer’s Association Welcomes FDA Advisory Committee Unanimous Vote of Efficacy of Donanemab for the Treatment of Early Alzheimer’s Disease

Recognizing AIM’s June Advocate of the Month: John Mathis